MMSI Quote, Financials, Valuation and Earnings

Boston Scientific has a net margin of 7.87% compared to Merit Medical Systems's net margin of 12.41%. Merit Medical Systems's return on equity of 9.36% beat Boston Scientific's return on equity of 8.96%.

Merit Medical Systems has a consensus price target of $117.82, signalling upside risk potential of 30.09%. On the other hand Boston Scientific has an analysts' consensus of $114.94 which suggests that it could grow by 20.67%. Given that Merit Medical Systems has higher upside potential than Boston Scientific, analysts believe Merit Medical Systems is more attractive than Boston Scientific.

Merit Medical Systems has a beta of 0.846, which suggesting that the stock is 15.356% less volatile than S&P 500. In comparison Boston Scientific has a beta of 0.728, suggesting its less volatile than the S&P 500 by 27.188%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.

Merit Medical Systems quarterly revenues are $355.2M, which are smaller than Boston Scientific quarterly revenues of $4.6B. Merit Medical Systems's net income of $27.9M is lower than Boston Scientific's net income of $566M. Notably, Merit Medical Systems's price-to-earnings ratio is 44.62x while Boston Scientific's PE ratio is 76.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 3.96x versus 8.45x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

ICU Medical has a net margin of 7.87% compared to Merit Medical Systems's net margin of -3.78%. Merit Medical Systems's return on equity of 9.36% beat ICU Medical's return on equity of -5.75%.

Merit Medical Systems has a consensus price target of $117.82, signalling upside risk potential of 30.09%. On the other hand ICU Medical has an analysts' consensus of $190.00 which suggests that it could grow by 36.55%. Given that ICU Medical has higher upside potential than Merit Medical Systems, analysts believe ICU Medical is more attractive than Merit Medical Systems.

Merit Medical Systems has a beta of 0.846, which suggesting that the stock is 15.356% less volatile than S&P 500. In comparison ICU Medical has a beta of 0.863, suggesting its less volatile than the S&P 500 by 13.724%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ICU Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. ICU Medical pays out -- of its earnings as a dividend.

Merit Medical Systems quarterly revenues are $355.2M, which are smaller than ICU Medical quarterly revenues of $629.8M. Merit Medical Systems's net income of $27.9M is higher than ICU Medical's net income of -$23.8M. Notably, Merit Medical Systems's price-to-earnings ratio is 44.62x while ICU Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 3.96x versus 1.42x for ICU Medical. Usually stocks with elevated PS ratios are considered overvalued.

Inogen has a net margin of 7.87% compared to Merit Medical Systems's net margin of -12.18%. Merit Medical Systems's return on equity of 9.36% beat Inogen's return on equity of -19.02%.

Merit Medical Systems has a consensus price target of $117.82, signalling upside risk potential of 30.09%. On the other hand Inogen has an analysts' consensus of $10.00 which suggests that it could grow by 45.35%. Given that Inogen has higher upside potential than Merit Medical Systems, analysts believe Inogen is more attractive than Merit Medical Systems.

Merit Medical Systems has a beta of 0.846, which suggesting that the stock is 15.356% less volatile than S&P 500. In comparison Inogen has a beta of 1.477, suggesting its more volatile than the S&P 500 by 47.732%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Inogen offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. Inogen pays out -- of its earnings as a dividend.

Merit Medical Systems quarterly revenues are $355.2M, which are larger than Inogen quarterly revenues of $80.1M. Merit Medical Systems's net income of $27.9M is higher than Inogen's net income of -$9.8M. Notably, Merit Medical Systems's price-to-earnings ratio is 44.62x while Inogen's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 3.96x versus 0.48x for Inogen. Usually stocks with elevated PS ratios are considered overvalued.

Masimo has a net margin of 7.87% compared to Merit Medical Systems's net margin of -58.2%. Merit Medical Systems's return on equity of 9.36% beat Masimo's return on equity of -23.05%.

Merit Medical Systems has a consensus price target of $117.82, signalling upside risk potential of 30.09%. On the other hand Masimo has an analysts' consensus of $195.70 which suggests that it could grow by 29.02%. Given that Merit Medical Systems has higher upside potential than Masimo, analysts believe Merit Medical Systems is more attractive than Masimo.

Merit Medical Systems has a beta of 0.846, which suggesting that the stock is 15.356% less volatile than S&P 500. In comparison Masimo has a beta of 1.278, suggesting its more volatile than the S&P 500 by 27.807%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Masimo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. Masimo pays out -- of its earnings as a dividend.

Merit Medical Systems quarterly revenues are $355.2M, which are smaller than Masimo quarterly revenues of $600.7M. Merit Medical Systems's net income of $27.9M is higher than Masimo's net income of -$349.6M. Notably, Merit Medical Systems's price-to-earnings ratio is 44.62x while Masimo's PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 3.96x versus 3.92x for Masimo. Usually stocks with elevated PS ratios are considered overvalued.